GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sedana Medical AB (FRA:7D2A) » Definitions » Gross-Profit-to-Asset %

Sedana Medical AB (FRA:7D2A) Gross-Profit-to-Asset % : 16.54% (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Sedana Medical AB Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Sedana Medical AB's annualized Gross Profit for the quarter that ended in Mar. 2025 was €14.84 Mil. Sedana Medical AB's average Total Assets over the quarter that ended in Mar. 2025 was €89.75 Mil. Therefore, Sedana Medical AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 16.54%.


Sedana Medical AB Gross-Profit-to-Asset % Historical Data

The historical data trend for Sedana Medical AB's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sedana Medical AB Gross-Profit-to-Asset % Chart

Sedana Medical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.09 12.03 7.38 10.31 12.23

Sedana Medical AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.44 11.15 11.08 13.45 16.54

Competitive Comparison of Sedana Medical AB's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Sedana Medical AB's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sedana Medical AB's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sedana Medical AB's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Sedana Medical AB's Gross-Profit-to-Asset % falls into.


;
;

Sedana Medical AB Gross-Profit-to-Asset % Calculation

Sedana Medical AB's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=10.966/( (90.654+88.623)/ 2 )
=10.966/89.6385
=12.23 %

Sedana Medical AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=14.844/( (88.623+90.881)/ 2 )
=14.844/89.752
=16.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Sedana Medical AB Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Sedana Medical AB's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sedana Medical AB Business Description

Traded in Other Exchanges
Address
Vendevagen 89, Danderyd, SWE, SE-182 32
Sedana Medical AB is a Sweden-based medical technology company. It is a pioneer MedTech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. The product range of the group is Sedaconda ACD, Sedaconda, AnaConDa, FlurAbsorb, Gas Monitor, Adapters, and Accessories. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.

Sedana Medical AB Headlines

No Headlines